These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30447913)

  • 1. One step ahead: miRNA-34 in colon cancer-future diagnostic and therapeutic tool?
    Krajewska JB; Fichna J; Mosińska P
    Crit Rev Oncol Hematol; 2018 Dec; 132():1-8. PubMed ID: 30447913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells.
    De Robertis M; Poeta ML; Signori E; Fazio VM
    Semin Cancer Biol; 2018 Dec; 53():232-247. PubMed ID: 30130662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Role of MicroRNAs in Colorectal Cancer].
    Kim SW
    Korean J Gastroenterol; 2017 Apr; 69(4):206-211. PubMed ID: 28449421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity.
    Hollis M; Nair K; Vyas A; Chaturvedi LS; Gambhir S; Vyas D
    World J Gastroenterol; 2015 Jul; 21(27):8284-92. PubMed ID: 26217080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as Regulator of Signaling Networks in Metastatic Colon Cancer.
    Wang J; Du Y; Liu X; Cho WC; Yang Y
    Biomed Res Int; 2015; 2015():823620. PubMed ID: 26064956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol.
    Sun G; Cheng YW; Lai L; Huang TC; Wang J; Wu X; Wang Y; Huang Y; Wang J; Zhang K; Hu S; Yang JR; Yen Y
    Oncotarget; 2016 Jan; 7(4):3857-72. PubMed ID: 26646696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA expression profile of colon cancer stem cells compared to non-stem cells using the SW1116 cell line.
    Fang Y; Xiang J; Chen Z; Gu X; Li Z; Tang F; Zhou Z
    Oncol Rep; 2012 Dec; 28(6):2115-24. PubMed ID: 23007737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer.
    Moridikia A; Mirzaei H; Sahebkar A; Salimian J
    J Cell Physiol; 2018 Feb; 233(2):901-913. PubMed ID: 28092102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation and SN38 treatments modulate the expression of microRNAs, cytokines and chemokines in colon cancer cells in a p53-directed manner.
    Pathak S; Meng WJ; Nandy SK; Ping J; Bisgin A; Helmfors L; Waldmann P; Sun XF
    Oncotarget; 2015 Dec; 6(42):44758-80. PubMed ID: 26556872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks.
    Shirafkan N; Mansoori B; Mohammadi A; Shomali N; Ghasbi M; Baradaran B
    Biomed Pharmacother; 2018 Jan; 97():1319-1330. PubMed ID: 29156521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of microRNAs in colonic field carcinogenesis: implications for screening.
    Kunte DP; DelaCruz M; Wali RK; Menon A; Du H; Stypula Y; Patel A; Backman V; Roy HK
    PLoS One; 2012; 7(9):e45591. PubMed ID: 23049818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin and insulin up-regulate miR-4443 to suppress NCOA1 and TRAF4, and decrease the invasiveness of human colon cancer cells.
    Meerson A; Yehuda H
    BMC Cancer; 2016 Nov; 16(1):882. PubMed ID: 27842582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific associations between miRNA expression and survival in colorectal cancer cases.
    Slattery ML; Herrick JS; Pellatt DF; Mullany LE; Stevens JR; Wolff E; Hoffman MD; Wolff RK; Samowitz W
    Oncotarget; 2016 Sep; 7(37):60193-60205. PubMed ID: 27517623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
    Yamamoto H; Mori M
    Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
    Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
    Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-suppressive miR-145 co-repressed by TCF4-β-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer.
    Wang W; Xiao X; Chen X; Huo Y; Xi WJ; Lin ZF; Zhang D; Li YF; Yang F; Wen WH; Yang AG; Wang T
    Int J Cancer; 2018 Jan; 142(2):308-321. PubMed ID: 28921929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.